LEXINGTON, Mass., Nov 22, 2011 (BUSINESS WIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the 23rd Annual Piper Jaffray Healthcare Conference on November 29 at 2:30 pm ET in New York City. Company management will provide a brief overview of the company followed by a question and answer period with investors.
A live webcast of each presentation will be accessible through the Investors section of the company’s website at https://www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit https://www.amagpharma.com.
SOURCE: AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
